Related Experiment Videos
[Compatibility and efficacy of Meditonsin]
Fortschritte Der Medizin
|March 29, 1984
Summary
Meditonsin, a mercury cyanide solution, showed no detectable mercury increase in blood or urine at recommended doses. In vitro tests confirmed its excellent antimicrobial effectiveness even at minimal concentrations.
Area of Science:
- Pharmacology
- Toxicology
- Microbiology
Background:
- Heavy metals like mercury are under scrutiny for ecological and therapeutic implications.
- Meditonsin is a 0.004% solution of mercury cyanide, necessitating investigation into its biological and chemical properties.
Purpose of the Study:
- To investigate the absorption, excretion, and renal effects of mercury cyanide (Meditonsin).
- To evaluate the chemical behavior of mercury cyanide and related mercury salts.
- To determine the in vitro antimicrobial efficacy of Meditonsin.
Main Methods:
- Analysis of mercury ion levels in blood and urine following administration.
- Assessment of kidney function.
- Chemical characterization of mercury compounds.
- In vitro antimicrobial testing against various microorganisms.
Main Results:
- No significant increase in blood mercury ions or urinary mercury excretion was observed in adults at recommended Meditonsin dosages.
- Meditonsin demonstrated potent antimicrobial activity in vitro, even at minimal inhibitory concentrations.
- The chemical behavior of mercury cyanide and other mercury salts was characterized.
Conclusions:
- The therapeutic use of Meditonsin at recommended doses does not appear to lead to mercury accumulation or increased excretion.
- Meditonsin exhibits significant in vitro antimicrobial properties, suggesting potential therapeutic applications.